Some biological characteristics and features of the mitotic regime of basal-like breast cancer living in the south-east of Ukrainе

Authors

  • T. Yu. Pogorеlaya
  • N. F. Shchurov

DOI:

https://doi.org/10.11603/mcch.2410-681X.2016.v0.i3.6936

Keywords:

basal-like breast cancer (BLBC), mitotic activity, mitotic regime, biological markers.

Abstract

Current treatment regimens for patients with breast cancer should consider molecular genetic type of tumor. To identify aggressive tumors in medical practice assess the proliferation marker Ki-67 and apoptosis marker p53, but there are no data about its prognostic value in patients BLBC living in the south-east ofUkraine. For low-grade tumors, which include BLBC, characterized by a high degree of mitotic activity. In patients with BLBC in more than 50 % cases there was detected infiltrating ductal carcinoma. The high degree of aggression BLBC in the south-east ofUkraineputs its study on a par with the major problems in oncoecology.

References

Shchepotyn, Y. B., Zotov, A. S., & Liubota, Y. Y. Faktorы ryska razvytyia mestnыkh retsydyvov ynvazyvnoho raka hrudnoi zhelezы . Onkolohyia, 4 (12), 347–350.

Furuse, M., & Fujita, K. (1998). Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J. Cell Biol, 7(141), 1539–1550.

Perou, C. M., Sorlie, T., & Eisen, M. B. (2000). Molecular portraits of human breast tumours. Nature, 406, 747–752.

Prat, A., Perou, C. M., & Prat, A. (2009). Mammary development meets cancer genomics. Nat Med, 15, 842–844.

Rouzier, R., Perou, C., & Symmans, W. (2005). Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin. Cancer. Res, 85.

Sorlie, T., Perou, C. M., & Tibshirani, R. (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA, 98, 10869–10874.

Sorlie, T., Tibshirani, R., & Parker, J. (2003). Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. USA, 100, 8418–8423.

Sotiriou, C., Neo, S. Y., & McShane, L. M. (2003). Breast cancer classification and prognosis based on gene expression profiles from a population based study. Proc. Natl. Acad. Sci. USA, 10393–10398.

Tang, P., Skinner, K. A., & Hicks, D. G. (2009). Molecular classification of breast carcinomas by immunohistochemical analysis: are we ready. Diagn. Mol. Pathol, 18, 125–132.

Tischkowitz, M., Brunet, J. S., & Begin, L. R. (2007). Use of immunohistochemical markers can refine prognosis in triple negative breast cancer. BMC Cancer, 1 (7), 134.

FindPatent. ru-patentnыi poysk, 20122016 http://www.findpatent.ru/patent/228/2282402.html.

Published

2016-11-21

How to Cite

Pogorеlaya T. Y., & Shchurov, N. F. (2016). Some biological characteristics and features of the mitotic regime of basal-like breast cancer living in the south-east of Ukrainе. Medical and Clinical Chemistry, (3), 17–21. https://doi.org/10.11603/mcch.2410-681X.2016.v0.i3.6936

Issue

Section

ORIGINAL INVESTIGATIONS